Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Same-Day Discharge Safe for Minimally Invasive Myomectomy

By HospiMedica International staff writers
Posted on 24 Feb 2016
Discharging women on the same day of undergoing minimally invasive myomectomy appears to be a safe option, according to a new study.

Researchers at Kaiser Permanente Northern California (Oakland, USA) conducted a retrospective case series involving 403 women who underwent minimally invasive myomectomy and were discharged the same day in order to estimate readmission rates. More...
The chart review was performed for outcomes of interest, including emergency department (ED) and urgent clinic visits within 48 hours, at seven days, and up to three months later, along with surgical and demographic characteristics.

The results showed that 88% of the patients were discharged to home the same day. Within 48 hours, just two patients (0.6%) were readmitted, both for postoperative fever, while seven patients (2%) visited the ED for pain or urinary retention; none of the patients made urgent care visits, and no patients were readmitted for life-threatening events or reoperation. A total of five patients (1.4%) were readmitted within three months. The study was published in the March 2016 issue of Obstetrics & Gynecology.

“Same-day discharge after minimally invasive myomectomy was found to have a low readmission rate and low health care utilization in the immediate postoperative period,” concluded lead author Katie Alton, MD, and colleagues. “Same-day discharge appears to be a safe option for healthy patients after undergoing an uncomplicated minimally invasive myomectomy.”

Myomectomy is a surgical procedure to remove uterine fibroids (leiomyomas), common noncancerous growths that appear in the uterus usually during childbearing years. Unlike a hysterectomy, which removes the entire uterus, myomectomy removes only the fibroids and leaves the uterus intact. Women who undergo myomectomy report improvement in fibroid symptoms, including heavy menstrual bleeding and pelvic pressure.

Related Links:

Kaiser Permanente Northern California



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.